SURVEY GENOMICS, INC.

Biotech · Private

Cytope-drop, a spatial barcoding platform for high-throughput spatially-resolved single-cell multiomics analysis

Grants
$1.5M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Pioneering assays for spatially-resolved single-cell multiomics$397,995
Federal grantDepartment of Health and Human Services · Phase II · Pioneering assays for spatially-resolved single-cell multiomics$1,091,941
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2410CELLGRO TECHNOLOGIES, LLC——
2411GLAX, LLC——
2412AMPEDRNA BIOSCIENCES LLC——
2413SURVEY GENOMICS, INC.——
2414ATLAS BIOLOGICS, LLC——
2415TRIPILL BIOTECHNOLOGY, CORP.——
2416ZYMtronix, Inc.—$3.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Methods And Compositions For Analyzing Cells And Their Constituentsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.